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Abstract
The penalty system implemented by Italian law still represents a barrier against psy-
choactive drugs and drug addiction, especially at a time when the age of first consump-
tion has considerably dropped. Presidential Decree n. 309 of October 9, 1990 entitled 
“Consolidation of the laws governing drugs and psychotropic substances, the prevention, 
treatment and rehabilitation of drug addicts”, and referred to as Presidential Decree 
309/90, is the reference text for the cultivation, production, trade and use of narcotics 
and other psychoactive substances in Italy. The Presidential Decree has its origins in 
the now-forgotten law of December 22, 1975, n. 685, amended by law 162/90, which 
provided a draft of the current Presidential Decree 309/90. The current text has been 
amended numerous times over the years.
INTRODUCTION
In ancient times, there was no moral problem regard-
ing the use of psychoactive substances, as they represent-
ed a fundamental part of the relationship to the Gods, 
a link with medicine, and a spiritual connection with 
the body. Psychoactive substances were closely linked 
to the religious experience. They were mainly used as 
an entheogenic agent during rituals of vision and com-
munication with the divine: peyote (“bread of the gods”) 
in Mexico, ayahuasca (“liana of spirits”) in the Amazon 
and Central America, iboga (“miraculous plant” or ”tree 
of knowledge”) in West Africa, kawa (“bitter, pungent, 
sour drink”) in the South Pacific, and cannabis in the 
East. Drugs were also used by philosophers, for their 
stimulant and exhilarating properties. The ancient 
Greeks used them to cheer up their banquets (hemp, 
henbane, opium, mandrake). In the Odyssey of Homer, 
the author tells that Helen gave wine mixed with opium 
to Telemachus, the son of Ulysses, to alleviate his pain. 
Even the ancient Romans used psychoactive substances. 
With the development of the Christian religion, drugs 
started being regarded as “evil”, and their use, either 
for medical or religious purpose, was severely punished. 
With the discovery of the New World, coca and tobacco 
were imported into Europe from Americas. In Europe, 
the development of scientific disciplines such as chem-
istry, pharmacology and medicine, restored the status of 
psychoactive drugs as active ingredients or excipients of 
medicines. In the second half of the 19th century, the 
use of drugs in Europe, either for recreative or medical 
use, spread considerably. Opium was used in pharma-
cies, even for children, due to its relaxing properties. 
Cocaine was preferred by intellectuals because it was 
regarded as a substance capable of amplifying critical 
and creative thoughts. In 1897, Bayer marketed heroin 
as a medicine to treat cough, respiratory problems and 
to fight morphine dependence. A year later, heroin was 
already a huge commercial success and was exported 
to more than twenty countries. In the 1930s, a num-
ber of “new psychoactive substances (NPS)”, as they 
were so called at the time, were synthetized in labora-
tories and marketed. For instance, amphetamines were 
prescribed to treat depression and the excessive use of 
hypnotic medicines; they were also used in the military 
sphere because of their anorectic and psychostimulating 
properties. In 1943, the “lysergic acid diethylamide”, or 
LSD, a hallucinogenic substance whose precursor can 
be extracted from the fungus ergot, was synthesised and 
was initially used as a stimulant in psychotherapy and to 
treat alcohol addiction. This review decribes for the first 
time the evolution of the National legislation on psycho-
active substances since the first laws at the beginning of 
20th Century till the Presidential Decree 309 of 1990 
and subsequent amendements.
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A wide-ranging search of relevant scientific literature 
has been performed using multidisciplinary databases 
(Scopus, PubMed, PubMedCentral, Research Gate, 
Medline, Google Scholar) and in legal search engines 
(NORMATTIVA, Regulatory archive of the Ministry of 
Health) with the aim to gather all relevant laws regarding 
psychoactive substances banning that were published 
from 1920 until December 2019. The used search keys 
were: Presidential Decree 309/90, Psychoactive Drug, 
NPS, Legislative Evolution. The search was limited to 
English language and Italian language materials, and all 
articles have been independently revised for content by 
three of the authors to verify their relevance within the 
framework of the present review. Only the articles that 
were ultimately considered relevant by at least two of 
the paper authors have been chosen.
RESULTS
The Italian legislation has always considered the pro-
duction and illicit trafficking of drugs a crime, adopting 
repressive measures and always more incisive sanctions 
on the basis of International Conventions. The drug 
legislation was initially inspired by the prohibitionist 
point of view, although part of the public opinion called 
for separate treatment of cannabis and its derivatives 
(so-called soft drugs), asking for their legalization. The 
first drug law of February 18, 1923, n. 396, was part of a 
political-social context radically different from now, and 
considered drug use as a “vice”. 
However, it provided for the punishability of the con-
sumers only if their conduct threatened public order. 
Morphine, cocaine and other “poisonous substances 
that in small doses give narcotic action” were controlled, 
identified and included in a specific list [2]. The 1930 
Rocco Code established a number of measures aiming at 
repressing the trade and use of illegal drugs and the facil-
itation of use [3]. The subsequent reform resulted in the 
decree-law n. 151 of January 15, 1934, which repealed 
the previous law and absorbed some of the provisions of 
the penal code [4]. This regulatory framework remained 
in force until the introduction of the law of October 22, 
1954, n. 1041, “Law on Narcotics - Discipline of their 
production, trade and employment” (law n. 1041, www.
gazzettaufficiale.it/eli/id/1954/11/12/054U1041/sg), 
which severely punished all possible conducts concern-
ing the narcotics, including detention for personal use 
[5]. This law took into account the control of cultivation, 
production and trade of the generally defined “psycho-
tropic drugs” with particular attention on opiates, and 
severely punished personal use outside medical pre-
scription. The spread of psychoactive substances in Italy 
began at the end of the 1960s, and has reached great 
proportions over the following decade. Given the inad-
equacy of the legislation, which was characterized by a 
merely repressive approach to the problem, providing 
for the punishability of the consumer who was consid-
ered as a delinquent, a political intervention was asked 
to the civil society that also took into account the social 
and health aspects of the drug phenomenon. 
Subsequently, the law “Disciplina degli stupefacenti 
e sostanze psicotrope. Prevenzione, cura e riabilitazi-
one dei relativi stati di tossicodipendenza. (Regula-
tion of narcotic drugs and psychotropic substances. 
Prevention, treatment and rehabilitation of the related 
states of drug addiction)” was introduced on December 
12, 1975 [6] (law n. 685, www.gazzettaufficiale.it/eli/
id/1975/12/30/075U0685/sg). For the first time, the law 
recognized the possibility of not punishing simple drug 
users for their own consumption. However, there was 
no precise definition of the concept of “small quanti-
ty”, which was therefore left to the complete discretion 
of the judges. For this reason, the Court of Cassation 
dictated guidelines to reach consensus, defining the 
concept of “small quantity” of drug that encompassed 
the notion of drug addiction. Furthermore, to reach a 
sentence of acquittal or conviction, it was required that, 
the magistrate, through scientific investigations, should 
understand the number of drug doses in addition to the 
nature and composition of the substance. During the 
1980s, the trend in drug use reached worrisome propor-
tions, with a significant increase of drug-related fatali-
ties involving drug overdoses, road accidents under the 
influence, the onset of drug-related diseases (AIDS, vi-
ral hepatitis) and the increase drug-related crime. Dur-
ing the 1990s, Italy and most European countries faced 
the increase and spread of psychoactive substances us-
ing law enforcement, prevention policies (training and 
education in schools) and treatment and social reha-
bilitation programs. The need to cope with the increase 
and diffusion of drugs brought about a new turning 
point in the evolution of Italian legislation, achieved 
by the with law n. 162 (Vassalli-Russo-Jervolino) [7] 
“Aggiornamento, modifiche ed integrazioni della leg-
ge 22 dicembre 1975, n. 685, recante disciplina degli 
stupefacenti e sostanze psicotrope, prevenzione, cura 
e riabilitazione dei relativi stati di tossicodipendenza. 
(Updating, modification and integration of law n. 685 
of December 22, 1975, regulating narcotic drugs and 
psychotropic substances, prevention, treatment and re-
habilitation of the relative states of drug addiction)” of 
June 26, 1990 (law n. 162, www.gazzettaufficiale.it/eli/
id/1990/06/26/090G0197/sg) [7] which provided a draft 
of the current Presidential Decree 309/90 [1]. This law 
restored the sanctions against holders of small quanti-
ties for personal non-therapeutic use. As a legislative in-
strument of intervention, the regulations in force were 
collected in a special consolidated text, the Presidential 
Decree 309/90, on the subject of the discipline of nar-
cotic drugs and psychotropic substances, prevention, 
treatment and rehabilitation of drug addicts. With the 
Presidential Decree 309/90, the laws n. 685 and n. 162 
and the applicative decrees issued by the Ministry of 
Health were unified, in order to align themselves on the 
resolutions adopted by the Member States of the Euro-
pean Community.
PRESIDENTIAL DECREE N. 309  
OF OCTOBER 9, 1990
The law of June 26, 1990 (n. 162) [7] introduced into 
the December 12, 1975 (law n. 685) [6] numerous mod-
ifications, suppressions, substitutions and insertions of 
articles and paragraphs. It was therefore necessary to 
reorganize the whole discipline through the elaboration 
























of a “single text”, which was adopted with the Presi-
dential Decree 309/90 [1]. Laws n. 685 and n. 162 [7] 
were thus unified with the implementing decrees issued 
by the Ministry of Health. Before April 1993 popular 
referendum, personal use was linked to the quantity of 
the substance used, which should not, however, exceed 
the “average daily dose”. Art. 73 was based on the sys-
tem of double track sanctions, which made a distinc-
tion between “soft drugs” and “hard drugs”. These drugs 
were divided into six tables. Tables 1 and 3 listed the so-
called hard drugs (e.g., ecstasy or coca leaves). Tables 1 
and 4 listed the so-called soft drugs (e.g., cannabis and 
derivatives). Finally, Tables 5 and 6 included products 
used for therapeutic purposes and containing substanc-
es mentioned in Tables 1-4, for their potential for abuse 
and dependence (e.g., anxiolytics, antidepressants and 
psychostimulants). 
The Presidential Decree n. 309 of October 9, 1990: 
“Testo unico delle leggi in materia di disciplina degli 
stupefacenti e sostanze psicotrope, prevenzione, cura 
e riabilitazione dei relativi stati di tossicodipendenza. 
(Consolidation of the laws governing drugs and psy-
chotropic substances, the prevention, treatment and 
rehabilitation of drug addicts)”, (www.gazzettauffi-
ciale.it/eli/id/1990/10/31/090G0363/sg) [1] referred as 
Presidential Decree 309/90, came into force in 1990, 
concerning the legal discipline of narcotic drugs and 
psychotropic substances together with rules for the 
prevention, treatment and rehabilitation of the relative 
states of drug addiction. It was divided into 12 different 
parts: 
• Title I - Authorities and schedules (articles 1-16)
• Title II - Authorization and permits (articles 17-25-
bis)
• Title III - Provisions relative to the cultivation and 
production, manufacture, use and wholesaling of     
narcotic and psychotropic substances (articles 26-37)
• Title IV - Provisions distribution (articles 38-49)
• Title V - Import, export and transit (articles 50-59)
• Title VI - Documentation and custody (articles 60-68)
• Title VII - Specific provisions governing the substanc-
es listed in tables IV, V and VI (articles 69-71)
• Title VIII - Penalties for illicit activities (articles 72-
103)
• Title IX - Information and educational measures (ar-
ticles 104-112)
• Title X - Regional, provincial and local authorities’ 
responsibilities. Services for drug addiction (articles 
113-119)
• Title XI - Preventive, curative and rehabilitation mea-
sures (articles 120-126)
• Title XII - Final provisions (articles 127-136)
Annexes to the Single Text on Narcotic Drugs
Title I indicates and reserves the responsibility for 
guiding and promoting the general policy of control, 
prevention and intervention in the sector of the Nation-
al Coordination Committee for Action against Drugs, 
and determines the general supervisory functions of 
the Ministry of Health and the Ministry of Internal Af-
fairs, as well as the particular powers of the Regions. 
The surveillance and control activities of the Police 
Forces are then established, as well as the tasks of in-
formation and operational coordination of the Central 
Directorate for Anti-drug Services, a joint association 
under direct orders of the Ministry of Internal Affairs. 
Articles 13 and 14 indicate the criteria for establishing 
the 6 Tables containing the list of controlled substances 
ordered by potential hazard, on the basis of which the 
criminal and administrative norms (Title I-VIII) apply 
differentiated punitive sanctions. Titles II, III, IV, V, VI 
and VII examine all aspects of the cultivation, produc-
tion, manufacture, distribution, use, import and transit 
of psychoactive drugs, laying down specific require-
ments for authorisation, documentation and commu-
nication of data and information. The evolution of the 
criminal law on psychoactive substances is detailed in 
Title VIII and deals specifically with the measures of “re-
pression” of illicit activities related to psychoactive sub-
stances, regarding both the treatment applied to the 
consumer and the limits of the criminal relevance of 
the conduct of detention. Titles IX, X and XI constitute 
a very articulated text that can be considered as the 
guiding principle of the law to give great effectiveness 
to the prevention, treatment and reintegration. In this 
context, a provision operating in the fields of informa-
tion, education, medical and social assistance has been 
established. The annexes consist of Tables. The first 
four Tables list all psychoactive drugs and psychotropic 
substances connected to the system of sanctions for il-
licit use and placed under International and National 
Control (Tables I and III major sanctions; Tables II and 
IV minor sanctions). The first four Tables also include 
preparations containing the substances listed in each 
of these Tables. The Table of Medicinal Products in-
dicates the medicinal drugs, with particular reference 
to the prescriptions of the medicinal products for pain 
therapy and the medicinal products used in the course 
of treatment for the cessation of addictions, based on 
narcotic and psychotropic active substances of current 
therapeutic use for human or veterinary use. The Table 
of Medicinal Products is divided into five sections A, B, 
C, D and E. In these Tables medicinal drugs are distrib-
uted according to their potential for abuse. The Tables 
also indicate the dispensing regime. Medicinal drugs 
with simplified prescriptive procedures are included 
in Annex IIIa. The evolution of the criminal law on 
psychoactive substances, currently represented by the 
Presidential Decree 309/90, has mainly considered four 
aspects: the legal treatment of the simple drug con-
sumer, the limits of criminal relevance concerning drug 
detention, the public intervention in prevention, treat-
ment/rehabilitation and the inclusion of new psychoac-
tive substances in the Tables of banned compounds. On 
the other hand, the regulatory system for the detection 
of psychoactive substances has remained substantially 
unchanged over time. This regulatory system for psy-
choactive substances is characterised by the absence of 
a general notion of “drug”. This means that the drug is 
not considered in terms of its origin (vegetable or syn-
thetic), consumption method (e.g., chewing, smoking, 
injection, oral intake) and ability to cause alterations in 
interpersonal relationships and with the environment. 
The difficulty found in the identification of a univocal 
notion has therefore induced the legislator to prefer the 
























“Tabular System”. In fact, in the Presidential Decree, 
only the substances included in annex Tables of the 
Presidential Decree 309/90 are considered as “psycho-
active substances”. The Presidential Decree n. 309 of 
1990 has been the first exhaustive act on the regulation 
of psychoactive substances traffick and use in Italy.
AMENDEMENTS OF THE PRESIDENTIAL 
DECREE 309/90 DURING THE YEARS
Referendum of 1993
A turning point came with Presidential Decree of 
June 5, 1993 “Abrogazione parziale, a seguito di refer-
endum popolare, del testo unico delle leggi in materia 
di disciplina degli stupefacenti e sostanze psicotrope, 
prevenzione, cura e riabilitazione dei relativi stati di 
tossicodipendenza, approvato con decreto del Presi-
dente della Repubblica 9 ottobre 1990, n. 309. (Par-
tial repeal, following a popular referendum, of the con-
solidated text of the laws on the discipline of narcotic 
drugs and psychotropic substances, prevention, treat-
ment and rehabilitation of the relative states of drug 
addiction, approved by Presidential Decree n. 309 of 




which amended 309/90. In particular, Article 72, para-
graph 1, which contained the prohibition of personal 
use and any unauthorised use of drugs and psychotro-
pic substances, was repealed. By repealing Article 75, 
paragraph 1, and Article 78 paragraph 1, letter b and c, 
the notion of dose limit (“average daily dose”) was also 
abolished. The positive effects of 309/90 – i.e. a reduc-
tion in the number of drug-related deaths, an increase 
in the number of people entering community detoxifi-
cation protocols, the seizure of ever greater quantities 
of drugs – were therefore hampered by the referendum 
promoted and won by the Radicals in 1993, as only the 
distribution of drugs remained illegal. Since the referen-
dum, and until 2006, even the detention of large quan-
tities of drugs was criminally irrelevant. In these terms, 
the jurisprudence had been oriented, considering ac-
ceptable the possession of tens of grams of heroin, and 
even the transfer aimed at “group consumption”. The 
regulatory framework had become both lax and unnec-
essarily rigorous. Lax at the user/drug dealer interface: 
without proof of sale, there was no illegal limit for pos-
session. Unnecessarily rigorous at the recovery: in sev-
eral cases, the drug addict who completed his stay in 
prison could be reincarcerated, even for minor crimes 
and despite rehabilitation, thus frustrating the efforts 
for recovery. 
Decree of September 23, 2004
With the implementation of European Commission 
Directive 2003/101/EC of November 3, 2003 [9], and 
the Decree of September 23, 2004 “Attuazione della di-
rettiva 2003/101/CE del 3 novembre 2003 della Com-
missione europea, per quanto concerne la classificazi-
one ed i valori di soglia di alcune sostanze soggette a 
controllo, con sostituzione degli allegati I e III al testo 
unico delle leggi sulla disciplina delle sostanze stupefa-
centi e psicotrope, di cui al decreto del Presidente della 
Repubblica 9 ottobre 1990, n. 309, come modificato 
dal decreto legislativo 12 aprile 1996, n. 258, recante 
il recepimento della direttiva 92/109/CEE relativa alla 
fabbricazione e all’immissione in commercio di talune 
sostanze impiegate nella fabbricazione illecita di stu-
pefacenti o di sostanze psicotrope. (Implementation of 
European Commission Directive 2003/101/EC of No-
vember 3, 2003, regarding the classification and thresh-
old values of certain substances subject to control, re-
placing Annexes I and III of the consolidated text of the 
laws on the regulation of narcotic drugs and psychotro-
pic substances, referred to in Presidential Decree n. 309 
of October 9, 1990, as amended by Legislative Decree 
n. 258 of April 12, 1996, transposing Directive 92/109/
EEC to the manufacture and the marketing of certain 
substances used in the illicit manufacture of narcotic 
drugs and psychotropic substances)” (www.myttex.net/
forum/attachment.php?aid=1590) [10], regarding the 
classification and threshold values of certain substances 
subject to control, Annexes I and III of the consolidated 
text of the laws governing narcotic drugs and psychotro-
pic substances were replaced by the following: Category 
I (1-phenyl-2-propanone, N-acetylanthranilic acid, lso-
safrol cis and trans, 3,4-methylenedioxyphenylpropan-
2-one, piperonal, safrole, ephedrine, pseudoephedrine, 
norephedrine, ergomethrine, ergotamine and lysergic 
acid), Category II (acetic anhydride, phenylacetic acid, 
anthranilic acid, piperidine and potassium permanga-
nate) and Category III (hydrochloric acid, sulfuric acid, 
toluene, ethyl ether, acetone and methyl ethyl ketone).
Law February 2, 2001 (n. 12) “Standards  
to facilitate the use of opioid analgesic drugs  
in the treatment of pain”
Further amendments followed with two impor-




30giorni=false) [11] entitled: “Norme per agevolare 
l’impiego dei farmaci analgesici oppiacei nella terapia 
del dolore – Indicazioni applicative. Rules to facilitate 
the use of opioid analgesic drugs in pain therapy – Ap-
plication guidelines” and law of February 21, 2006 
“Conversione in legge, con modificazioni del decreto-
legge 30 dicembre 2005, n. 272, recante misure ur-
genti per garantire la sicurezza ed i finanziamenti per 
le prossime Olimpiadi invernali, nonché la funzionalità 
dell’Amministrazione dell’interno. Disposizioni per fa-
vorire il recupero di tossicodipendenti recidivi. (Con-
version into law, with amendments to decree-law n. 272 
of December 30, 2005, containing urgent measures to 
guarantee the safety and funding for the next Winter 
Olympics, as well as the functionality of the internal 
administration. Provisions to encourage the recovery of 
recidivist drug addicts)”. For the first time, By law n. 12, 
by the more and more pressing requests from patient 
associations in terminal phase were received with the 
aim of facilitating prescription and administration the 
following active substances (Annex III-bis): buprenor-
phine, codeine, dihydrocodeine, fentanyl, hydrocodone, 
























hydromorphone, methadone, morphine, oxychodone, 
oxymorphone, in pain treatments for patients suffering 
from severe pain due to neoplastic or degenerative pa-
thology. The offences, in prescription and dispensation, 
were all decriminalized and penalties were reduced to 
administrative pecuniary sanctions. 
Law February 21, 2006, (n. 49)
The deppest revision of 309/90 was brought with 
the law of February 21, 2006, (law n. 49 - www.
gazzettaufficiale.it/eli/gu/2006/02/27/48/so/45/sg/pdf 
[12] “Conversione in legge, con modificazioni del de-
creto-legge 30 dicembre 2005, n. 272, recante misure 
urgenti per garantire la sicurezza ed i finanziamenti per 
le prossime Olimpiadi invernali, nonché la funzional-
ità dell’Amministrazione dell’interno. Disposizioni per 
favorire il recupero di tossicodipendenti recidivi. (Con-
version into law, with amendments to decree-law n. 272 
of December 30, 2005, containing urgent measures to 
guarantee the safety and funding for the next Winter 
Olympics, as well as the functionality of the internal 
administration. Provisions to encourage the recovery of 
recidivist drug addicts)”, conversion of decree-law De-
cember 30, 2005 (n. 272) [13].
With the law n. 49, also known as Fini-Giovanardi, 
all psychoactive substances that did not find any thera-
peutic use were included in a single Table that did not 
discriminate “soft” and “hard” drugs for personal use, 
resulting in equal sanctions. The former six Tables were 
reduced to two, of which only the second, subdivided 
into sections A to E by dependence liability, was rel-
evant from a therapeutic and legal point of view. The 
rigorous choice of equalisation had, however, been mit-
igated by the reduction of the minimum penalty and 
the existence of mitigating circumstances referred to 
in art. 73, paragraph 5. The new system of sanctions 
– administrative and criminal – aimed to combine pre-
vention, repression and recovery, assuming that drug 
use is not an innocuous exercise of freedom, but an 
act of rejection of the most basic duties of the indi-
vidual towards the different communities in which he 
lives. The punishment of drug possession was reintro-
duced and a boundary was established between deten-
tion, which represents an administrative offence, and 
detention, which constitutes a criminal offence. The 
boundary was no longer represented by the “small 
quantity”, which was subjective and arbitrary, nor the 
“average daily dose”, but an objective quantitative Ta-
ble for substance: if the drug in possession exceeded 
a certain limit, criminal sanctions were applied; if the 
quantity was below that limit, administrative sanctions 
were applied (suspension of the driving licence, weapon 
licence, passport, residence permit for tourists, and ad-
ministrative detention of the scooter in use). With the 
new law, the criminal sanctions were gradual. For users 
who had committed a minor crime, a completely new 
measure was introduced if the person did not want to 
go through rehabilitation and had already been granted 
a sentence suspension: instead being incarcerated and 
upon request, convicted people could do public util-
ity work for the entire duration of the prison sentence. 
Confirming existing provisions, which were made more 
appropriate to the seriousness of the crimes, recovery 
was favored from the moment when pre-trial deten-
tion was ordered: detention could be avoided by going 
under house arrest and starting, under certain condi-
tions, a therapeutic program. To have a better chance 
of undergoing therapy, the possibility of suspending 
the execution of the final prison sentence was widened: 
the limit of punishment allowing suspension was raised 
from 4 to 6 years of imprisonment, which allowed a 
larger number of drug addicts to go through rehabili-
tation. The reform also had a profound impact on the 
management of drugs. It was important for both the 
doctor and the pharmacist to replace the old “two cop-
ies” prescription with the “tracing“ one, reserving the 
use of only one category of medicines (Table II, Sec-
tion A) and a maximum lenght of 30 days. In order to 
limit illicit activities associated with therapeutic use, the 
new discipline provided a draft of a copy of the pre-
scription, limited to section A, which the patient must 
hold as proof of legal possession of the drug prepara-
tion. Galenic preparations may then be prepared only 
with the narcotic active ingredients listed in Section B 
of Table II, and the validity of the galenic and renew-
able prescription was limited to 30 days. The extension 
of section E prescriptions could not exceed three times 
in the 30 days of validity. A vouchers-purchase bulletin 
is necessary for cumulative orders. Although official, 
this bulletin is not printed by the State Polygraph and 
can be downloaded and printed directly from the Min-
istry’s website and coexists with the old official model 
bulletin, which can only be used for one substance or 
preparation. Like all laws, the discipline of narcotics 
also needed rules of application and interpretation. It 
has been clarified that the discharge from the register 
of substances and preparations for destruction can only 
be made when the pharmacist loses the material pos-
session of narcotic drugs to no availing itself of the pos-
sible entrustment by the Local Healthcare Units after 
drawing up a special report (Ministerial Health Note 
May 31, 2006 N. D.G.F.D.M/VIII/P/I.8d.q/20116). It 
has also been made clear that the compilation, of the 
voucher-purchase bulletin can be carried out also by a 
pharmacist other than the holder or director, provided 
that it was authorized for this purpose by formal act 
(Ministerial Health Note May 20, 2008 N. 0019201-
P- 20/05/2008 DGFDM). Finally, as far as the model 
of the entry and exit register is concerned, the Ministry 
has clarified that the number of pages can be different 
from 200. This clarification therefore allows for regis-
ters with less than 200 pages to be set up and, conse-
quently, to replace them more frequently, thus being 
able to destroy the prescriptions downloaded two years 
after the last registration, with an obvious advantage for 
the confidentiality of personal data.
Ministerial Decree of April 18, 2007
Subsequently, Ministerial Decree of April 18, 2007 
“Aggiornamento e completamento delle Tabelle conte-
nenti l’indicazione delle sostanze stupefacenti e psico-
trope e relative composizioni medicinali, di cui al de-
creto del Presidente della Repubblica 9 ottobre 1990, n. 
309, e successive modificazioni ed integrazioni, recante 
























il testo unico delle leggi in materia di disciplina degli 
stupefacenti e sostanze psicotrope e di prevenzione, 
cura e riabilitazione dei relativi stati di tossicodipen-
denza”. (Update and completion of the Tables in the 
Presidential Decree n. 309/90, www.trovanorme.salute.
gov.it/norme/dettaglioAtto?completo=si&id=23064) 
[14], was amended by the decree of April 29, 2007. 
The prescription of opioid analgesic medicinal products 
(Annex III-bis) was no longer limited to the treatment 
of severe pain caused by neoplastic or degenerative 
pathology. Therefore, these medicinal products can be 
used for the therapy of the severe pain (postoperative, 
trauma...), regardless of the origin of the pain itself. 
New substances were also added to Table I: total opium 
alkaloids, beta-hydroxymethyl-3-fentanyl, buprenor-
phine, intermediate destromoramide, (+) - 1 - methyl 
- lysergic acid diethylamide, morphine methyl bromide 
and other morphine derivatives with {pentavalent ni-
trogen} including N-oxymorphine derivatives (such as 
N-oxycodeine). For the same decree, the following sub-
stances were also removed from Table I: ethylcyclidine 
and ethyl ester of 4-phenylpiperidin-4-carboxylic acid. 
In the same Table, the common name of messalina has 
also been replaced by the common name of mescaline. 
New substances were also added to Table II, section 
B: delta-9-tetrahydrocannabinol, trans-delta-9-tetrahy-
drocannabinol and nabilone, while tramadol and the 
compositions containing this substance were removed 
from section B and D of the same Table. Moreover, me-
dicinal compositions for uses other than the injectable 
ones containing destropropoxyfen in association with 
other active ingredients were moved from section D to 
section E of Table II.
The Ordinances of the Vice-Minister Fazio  
(June 16 and July 2, 2009)
Additional ministerial intervention consisted of the 
Ministerial Ordinance of June 16, 2009 “Iscrizione tem-
poranea di alcune composizioni medicinali nella Tabella 
II, sezione D, allegata al testo unico delle leggi in mate-
ria di disciplina degli stupefacenti e sostanze psicotrope 
e di prevenzione, cura e riabilitazione dei relativi stati 
di tossicodipendenza. (Temporary entry of certain me-
dicinal compositions in Table II, Section D, attached 
to the consolidated text of laws on the regulation of 
narcotic drugs and psychotropic substances and on the 
prevention, treatment and rehabilitation of the relative 




with substances such as opioids, certain pharmaceuti-
cal forms, to a limited extent, and authorized analgesic 
substances, were transferred from section A to section 
D of Table II (buprenorphine, codeine, dihydroco-
deine, fentanyl, hydrocodone, hydromorphone, oxyco-
done, morphine, oxymorphone). The measure, which 
was followed by another Ordinance on July 2, 2009 
“Supplements to the Ordinance of 16 June 2009 on 
“Integrazioni all’ordinanza 16 giugno 2009, recante Is-
crizione temporanea di alcune composizioni medicinali 
nella tabella II, sezione D allegata al testo unico delle 
leggi in materia di disciplina degli stupefacenti e sos-
tanze psicotrope e di prevenzione, cura e riabilitazione 
dei relativi stati di tossicodipendenza. (Temporary entry 
of certain medicinal compositions in Table II, Section 
D attached to the consolidated text of laws on the dis-
cipline of narcotic drugs and psychotropic substances 
and on the prevention, treatment and rehabilitation of 
their states of drug addiction” (www.gazzettaufficiale.
it/eli/id/2009/07/08/09A08111/sg) [16] involved the fol-
lowing practical effects for physicians and pharmacists:
• use of personal prescription of the doctor or the Na-
tional Healthcare System;
• overcoming, without limits, of the dose for thirty days 
of treatment (except in the case of National Health-
care System prescription);
• deletion of input and output recording;
• the obligation to store psychoactive drugs in a closed 
locker no longer applies;
• purchase without filing the bulletin (in the sole case 
of purchase from a wholesaler);
• destruction of prescriptions retained after six months;
However, with the Ministerial Ordinance of July 2, 
2009, the obligation to identify the purchaser in the 
case of personal prescription was introduced. The goal 
was to avoid the circulation of falsified prescriptions 
without possibility to trace the person responsible for 
the presentation. The obligation to send to the Local 
Healthcare Unit and the Order of Pharmacists, by the 
end of each month, a summary communication of the 
prescriptions sent privately (white prescription) in the 
previous month was also provided for.
Law March 15, 2010 (law n. 38) “Arrangements  
to ensure access to palliative care and pain therapy”
After a process that lasted almost two years, law of 
March 15, 2010 (law n. 38, www.gazzettaufficiale.it/
gunewsletter/dettaglio.jsp?service=1&datagu=2010-03-
19&task=dettaglio&numgu=65&redaz=010G0056&t
mstp=1269600292070) [17], entitled “Disposizioni per 
garantire l’accesso alle cure palliative e alla terapia del 
dolore. (Provisions to ensure access to palliative care 
and pain therapy)”, was published in the Official Ga-
zette n. 65 of March 19, 2010. The law had a very strong 
impact on the prescription and dispensing of medicines 
used in pain therapy. The rules were contained in art. 
10 entitled “Simplification of procedures for access to 
medicines used in pain therapy” and intervened signifi-
cantly on various articles of Presidential Decree n. 309 
of October 9, 1990, which regulates narcotic drugs and 
psychotropic substances. The following amendments 
were enforced on April 3, 2010.
Article 14 (Table). The amendment to Article 14 
provided for the inclusion in Section D of Table II of 
all medicinal products containing substances listed in 
Annex III-bis to Presidential Decree 309/90, namely: 
buprenorphine, codeine, dihydrocodeine, fentanyl, hy-
drocodone, hydromorphone, methadone, morphine, 
oxycodone, oxymorphone, provided that they are not 
parenteral preparations. The Ministry of Health was 
forced to amend the Table because the provision of law 
could be fully implemented.
Article 25-bis (destruction). Article 25-bis greatly 
























simplified the procedures for the destruction of psycho-
active substances. The destruction could be carried out 
by allowed private companies which had to provide a 
report to be transmitted to the Local Heathcare Unit 
by the Pharmacy Director. 
Article 38 (vouchers). The amendment to art. 38 
removed the requirement for a written request to pur-
chase medicinal products from Sections D and E, when 
purchased from suppliers other than wholesalers. In es-
sence, the obligation to complete the bulletin only re-
mained for medicinal products belonging to sections A, 
B and C, in all procurement scenarios.
Articles 41 and 43 (receivers). Indication of the ad-
dressees of simplified forms for prescription analgesic 
medicinal products (art. 41 and 43) passed from pa-
tients affected by severe pain during pathology neoplas-
tic or degenerative to that more generic and extensive 
of patients who had access to palliative care and pain 
therapy. 
Article 43 (medical prescription book). Paragraph 
4-bis Article 43 provided for the possibility of the pre-
scription of medicinal products belonging to section 
A, to be on the health service’s medical preascription 
book national. However, it was obvious that, if the 
doctor prescribed the medicine of section A not under 
National Healthcare System control, only the medical 
prescription book must be used to Ministerial tracing.
Article 45 (buyer’s documents). With regard to the 
obligations of the pharmacist in the dispensation of 
Section A medicinal products (art. 45, 1st paragraph), it 
should be ensured that (the pharmacist) the identity of 
the purchaser and took note of the extremes of an iden-
tification document from transcribe on the prescription 
to the following forecast that noted on the prescription 
the first name, last name and contact details of the buy-
er’s identification document.
Article 45 (excess therapy). The legislator wanted 
to overcome the following problem: the pharmacist 
still sent out the prescriptions that should prescribe a 
quantity which, in relationship to the indicated dosage, 
theoretically exceeded the maximum limit of 30-day 
therapy, where the surplus was due to the number of 
contained dosage units in the packages on the market. 
The pharmacist was also allowed to reduce the number 
of packages to fit in with the requirements of the 30 
days of therapy, taking into account however, the pre-
vious forecast was present and communicating to the 
doctor.
Article 45 (fulfilments). Paragraph 6-bis, added to 
Article 45, concerned the pharmacist’s obligations if 
presented with a prescription, so-called white, prescrib-
ing medicines which, according to the ordinance of 16 
June 2009 and this law, have passed, and will pass, from 
section A to section D.
Article 45 (reduced delivery). For all prescribed 
medicinal products and belonging to Sections A to E, 
the possibility was provided for, on request of the pa-
tient, reduced delivery than the prescribed quantity by 
giving communication to the doctor, or but in any case 
by the end of the year. 30-day period of validity of the 
prescription and reporting on it the quantities delivered 
from time to time (Article 45, paragraph 10-bis).
Article 60 (logbook). The amendment to Article 60 
reduced to two years the conservation period of the en-
try and exit register date of last registration. In this way, 
the conservation time of the prescriptions of sections 
A, B and C (two years) was brought into line with the 
conservation time of the register and, obviously, of all 
the accompanying documents (bulletins, vouchers, re-
ports of destruction, theft, etc.). In addition, art. 60, as 
amended, provided that the number of pages could be 
different from two hundred and adequate to the amount 
of drugs that would normally taken over and sold.
Article 68 (decriminalizations). Finally, with the 
addition of paragraph 1-bis to art. 68, the irregularities 
found relating to breaches of the regulations on record 
keeping were decriminalised.
Sentence n. 32/2014 of the Constitutional Court
With decree-law of March 20, 2014 “Disposizioni 
urgenti in materia di disciplina degli stupefacenti e 
sostanze psicotrope, prevenzione, cura e riabilitazione 
dei relativi stati di tossicodipendenza, di cui al decreto 
del Presidente della Repubblica 9 ottobre 1990, n. 309, 
nonché di impiego di medicinali meno onerosi da parte 
del Servizio Sanitario Nazionale. (Urgent provisions 
concerning the regulation of narcotic drugs and psycho-
tropic substances, prevention, treatment and rehabilita-
tion of the relative states of drug addiction, as per Presi-
dential Decree n. 309 of 9 October 1990, as well as the 
use of less onerous medicines by the National Health-
care Service)”, law n. 36, (www.gazzettaufficiale.it/eli/
id/2014/3/21/14G00047/sg) [18], several amendments 
were made to the Presidential Decree n. 309/90, follow-
ing sentence of 2014, n. 32 (www.cortecostituzionale.it/
actionSchedaPronuncia.do?anno=2014&numero=32) 
[19], of the Constitutional Court, which reinstated the 
distinction between “soft” and “hard” drugs. Compared 
to the original single Table of Drugs, the decree-law 
returned to four Tables (plus a Table of “Medicines”), 
and considered separately cannabis and its derivatives, 
which ended up in the Second Table. The second excep-
tion concerned the sanctions: as a result of the com-
bined effect of the new decree and the ruling of the 
Constitutional Court, the penalty system of the law n. 
162 was revised. In this concern the penalties for im-
prisonment in case of possession of significant cannabis 
quantities and the trafficking of cannabis and its deriva-
tives were again significantly reduced.
Moreover, a new Table of medicinal products was 
established to allow complete continuity in the pro-
duction, prescription, and distribution of psychoactive 
medicinal products, with particular reference to the 
prescriptions of pain therapy medicinal products and 
medicinal products used in the course of treatment for 
the cessation of addictions. The modalities of prescrip-
tion and dispensing therefore remained unchanged for 
all therapies with psychoactive drugs; the modalities of 
management of the medicines by the operators of the 
pharmaceutical sector also remained unchanged.
Therapeutic use of cannabinoids in Italy
Ministerial Decree 98/2007 “Aggiornamento e 
completamento delle Tabelle contenenti l’indicazione 
























delle sostanze stupefacenti e psicotrope e relative com-
posizioni medicinali, di cui al decreto del Presidente 
della Repubblica 9 ottobre 1990, n. 309, e successive 
modificazioni ed integrazioni, recante il testo unico 
delle leggi in materia di disciplina degli stupefacenti e 
sostanze psicotrope e di prevenzione, cura e riabilitazi-
one dei relativi stati di tossicodipendenza. (Update and 
completion of the Tables containing the indication of 
narcotic and psychotropic substances and related me-
dicinal compositions” as per Presidential Decree n. 309 
of 9 October 1990 and subsequent amendments and 
additions, containing the consolidated text of the laws 
on the regulation of narcotic drugs and psychotropic 
substances and on the prevention, treatment, rehabili-
tation of their states of drug dependence) (www.trova-
norme.salute.gov.it/norme/dettaglioAtto?completo=si
&id=23064) has recognized the therapeutic properties 
of delta-9-tetrahydrocannabinol (THC), the main ac-
tive ingredient of cannabis, and two other analogs of 
synthetic origin (dronabinol and nabilone). These sub-
stances are listed in Table II section B (art. 2), which 
lists the substances that can be used in therapy and 
prescribed according to Article 72, paragraph 2, of the 
consolidated law 309/90. 
With the Ministerial Decree n. 33 of 2013, an update 
of the Tables containing the indication of narcotic and 
psychoactive substances was made, inserting in Table II 
section B the “medicinal products of vegetable origin 
based on cannabis (herbal substances and preparations, 
including extracts and tinctures” (www.gazzettaufficia-
le.it/eli/id/2013/02/08/13A00942/sg).
To the present day, the current classification of canna-
bis and derivatives, is finally dictated by the law n. 79/2014 
(www.gazzettaufficiale.it/eli/id/2014/05/20/14G00090/
sg), which confirms the therapeutic function of the 
substances mentioned above and therefore their in-
clusion in Table II section B, now renamed “Table of 
Medicines”. However, the law also classifies tetrahydro-
cannabinol (THC) and its analogues in Table I (most 
dangerous substances), and cannabis and its derivatives 
– oil, resin, leaves and inflorescences – in Table II (sub-
stances with a lower risk of addiction). 
Production, distribution and use of medical cannabis
According to art. 26 of Presidential Decree 309/90 
“(…) the cultivation of the plants included in Table I 
and II of art. 14 (…) is forbidden in the territory of 
the State”, however “the Minister of Health can autho-
rize university institutes and public laboratories with 
institutional research purposes, to cultivate the above-
mentioned plants for scientific, experimental or didac-
tic purposes”. Thanks to this exception, the Ministry of 
Health and the Ministry of Defence signed an agree-
ment on September 18, 2014, under which the military 
chemical-pharmaceutical plant (SCFM) in Florence 
now carries out the operations of cultivation and manu-
facture of the active substance of plant origin based on 
cannabis. It also provides for the packaging and distri-
bution, upon request of the Regions and Autonomous 
Provinces, to local pharmacies or hospital pharmacies 
for the preparation of magisterial preparations, to be 
dispensed on presentation of a non-repeatable pre-
secription, in order to meet the needs of the assisted 
population. The active herbal substance is therefore 
supplied by the SCFM or can be found abroad, fol-
lowing a series of procedures regulated by the decree 
of February 11, 1997 entitled “Methods of importing 
specialty medicines registered abroad”, which allows 
the importation of drugs not distributed in the Italian 
Health circuit.
The Ministerial Decree of November 9, 2015 “Func-
tions of the State Agency for cannabis provided for 
in Articles 23 and 28 of the Single Convention on 
Narcotic Drugs of 1961, as amended in 1972” (www.
gazzettaufficiale.it/eli/id/2015/11/30/15A08888/sg) has 
laid down more detailed provisions on the subject. Ar-
ticle 1 has identified the precise functions of the Minis-
try of Health as the State Agency for cannabis, which:
• authorises the cultivation of cannabis plants for use in 
the manufacture of herbal medicinal products based 
on cannabis;
• identifies the areas of use for such cultivation;
• imports, exports and distributes across the national 
territory, i.e. it authorises the import, export, whole-
sale distribution and maintenance of stocks of can-
nabis plants and material;
• provides for the determination of the production 
quotas of active substances of plant origin based on 
cannabis on the basis of the requests of the Regions 
and Autonomous Provinces and informs the Interna-
tional Narcotics Control Board (INCB) at the Unit-
ed Nations.
A technical annex to the Ministerial Decree has 
dealed with the most practical issues:
• the dosage of the medicinal product is determined, as 
well as the the mean of production and distribution 
to pharmacies;
• States that treatments with cannabis cannot be con-
sidered “a therapy in the strict sense of the word”, but 
only to palliate the standard treatments when they 
have not produced the desired effects or have caused 
side effects that cannot be tolerated;
• the possible therapeutic uses of cannabis are exhaus-
tively indicated for diseases involving spasticity and 
pain (multiple sclerosis, spinal cord injury); chronic 
pain; nausea and vomiting caused by chemotherapy, 
radiotherapy and HIV therapy; with appetite-stimu-
lating effect in cachexia, anorexia, oncology or AIDS 
patients; with hypotensive effect in glaucoma; for re-
duction of involuntary bodily and facial movements 
in Tourette’s syndrome);
• a phytosurveillance system will be set up, and ther-
apeutic responses to cannabis will be monitored, 
thanks to reports made by health professionals to the 
Istituto Superiore di Sanità about any suspected ad-
verse reactions following administration.
Currently, Italy allows the exclusive therapeutic use 
of cannabinoids in the form of magisterial preparations 
based on cannabis, i.e. galenic drugs (e.g., tinctures, in-
fusions, oils, extracts) prepared by the pharmacist in his 
laboratory. The only drug of synthetic origin, based on 
cannabinoids, and authorised for trade by Italian Medi-
cines Agency is Sativex, which can only be used in the 
symptomatic treatment of muscle spasms in patients 
























with multiple sclerosis. The latter is a class H drug, and 
can therefore be supplied at the expense of the NHS 
only in the hospital environment and dispensed through 
hospital pharmacies and the territorial system.
New Psychoactive Drugs (NPS)
All narcotic drugs and psychoactive substances are 
now listed in Tables I, II, III and IV, which account for 
the substances with strong addictive liability and po-
tential for abuse in decreasing order; these Tables are 
amended whenever there is a need to introduce or re-
move a new substance or change its location. These Ta-
bles, linked to the system of sanctions for illicit use, list 
the narcotic and psychoactive substances placed under 
International and National control. The Table of me-
dicinal products, itself divided into 5 sections (A, B, C, 
D, E), displays the medicinal products containing nar-
cotic and psychotropic active substances and currently 
used for therapeutic purposes in human or veterinary 
medicine, and exemptions for doctors, pharmacists and 
operators in the pharmaceutical sector. In addition, An-
nex III-bis of the same decree contains the medicines 
used in pain therapies, which benefit from simplified 
prescriptive procedures, marked in the Tables with a 
double asterisk.
Since July 2007, by separate decrees of the Minis-
try of Health entitled “Update of the Tables containing 
the indication of narcotic and psychoactive substances, 
as per Presidential Decree n. 309/90, and subsequent 
amendments and additions”. Many new psychoactive 
substances (Table 1 of this article), have been included 
in Table I [20-56].
“Substances with an analogy” were also included in 
Table I, and include substances with similar chemical 
structure or effects to the substances already present 
in the same Table (2-amino-1-phenyl-1-propanone, 
indazol-3-carboxamide, indol-3-carboxamide, 3-benzo-
ylindole, 3-phenylacetylindole, 3-(1-naphthoyl)indole). 
Bupropion and pyrovalerone have been excluded from 
Table I. In Table II, herbal medicinal products based 
Table 1
New psychoactive substances included in Table I, Presidential Decree n. 309790, since 2007
Cathinones Phenethylamines Synthetic cannabinoids New synthetic opioids
4-MEC 2C-E XLR-11 Furanylfentanil
Ethylone 25H-NBOMe 5F-Apinaca 3-Phenylpropanoylfentanyl
Buphedrone 2C-H 5F-APP-Pica 4-Fluoroisobutyrfentanyl (4F-iBF)
Pentedrone 25E-NBOMe 5F-APP-Pinaca Benzylfentanyl
Alpha-PVT 4Cl-iBF 5F-PB22 Benzoylfentanyl
4F-NEB 25B-NBF AB-Chminaca Carfentanyl
Alpha-PHP 25B-NBOH AB-Fubinaca Cyclopentylfentanyl
Alpha-PVP DOC ADB-Chminaca Cyclopropylfentanyl
BK-2C-B 3,4-DMA NBOMe ADB-Fubinaca Benzodioxolefentanyl
Isopentedron 4-EA NBOMe APP-Fubinaca Methoxyacetylfentanyl
Methylone HHMA BB-22 Tetrahydrofuranylfentanyl (THF-F)
bk-MBDB HMA Cumil-5F-Pinaca Tetramethylcyclopropanfentanyl
Amfepramone HMMA MDMB-Chmica Thiophenefentanyl
3.4-Methylenedioxypyrovalerone 
(MDPV)
25B-NBOMe CP 47,497 Butyrfentanil
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on cannabis in Section B (substances and vegetable 
preparations, including extracts and dyes), nandrolone 
in Section A and tapentadol in Section D (previously 
included in Table II Section A) have been included re-
spectively. Amfepramone and phentermine, have been 
excluded from Table II Section B. In Table IV, fonaz-
epam (benzodiazepine analogue of flunitrazepam), 
methylmorphonate (methylphenidate anologue), suf-
entanil for sublingual use, etizolam and meprobamato 
have been included. In the Table of Medicinal Prod-
ucts, section D, lormetazepam has been included to the 
section “Compositions for use parenteral”. In addition, 
the use of propilesedrine, except for the manufacture of 
barbesaclone, has been excluded. Moreover, the follow-
ing substances have been excluded from the Table of 
Medicinal Products, Section B (dextropropoxyphene, 
fenproporex, mefenorex, meprobamate and tetraz-
epam), section C (dextropropoxyphene) and section E 
(meprobamate, dextropropoxyphene and tetrazepam). 
Conversely, cannabis-based herbal medicinal products 
have been included as usable in pain therapy in the 
Table of Medicinal Products, Section B. In Annex III-
bis, tapentadol has been added to the list, previously 
included in Table II Section A. These decisions have 
been taken “to protect public health, in view of the risks 
associated with the use and spread of new psychoac-
tive substances onto the international market”, as the 
world of drugs is evolving every day, and has consider-
ably changed in the last 10 years, with different forms of 
addiction, substances and modes of consumption.
CONCLUSION
The areas addressed offer an opportunity to recall 
that, in the Italian law, the penalty system for drug use 
and trafficking is based on Tables, and illicit conduct 
concerning (only) substances that are included in the 
“Tables” referred to in Articles 13 and 14 of Presidential 
Decree n. 309/90 are punished. The fact that the Min-
istry of Health, an administrative authority, has been 
entrusted with the task of drawing up and amending 
the “Tables” determines the construction of the criminal 
cases concerning narcotic or psychoactive substances 
as “blank criminal regulations”, in which the sanction is 
determined by a legislative act, while the illegal conduct 
is only partly described, since it must be specified by the 
Ministerial Decree governing the individual substances. 
The adoption of the tabular system of substances sub-
ject to control determines that only conduct concerning 
substances included in the “Tables” may be sanctioned, 
both criminally and administratively. It is worth repeat-
ing the need for the complete and timely updating of 
these Tables, to avoid the effect of punishing conduct 
involving substances that, although dangerous, have not 
been tabulated. The problem arises in all its emergence 
for the so-called new psychoactive drugs (NPS) freely 
available on the Internet, although they produce stimu-
lating and hallucinogenic effects similar to those of 
banned substances. They are obtained by modifying the 
chemical structures of the main illegal substances to ob-
tain new substances that are not controlled and, for this 
reason, are called “legal highs”. They are unregulated 
and untested. Given that the chemicals in these drugs 
are constantly changing to stay ahead of the law, it’s 
possible to receive a very different product from batch 
to batch, even if the packaging and name are the same. 
The new molecules detected by the European Monitor-
ing Centre for Drugs and Drug Addiction (EMCDDA) 
in 2018 are about sixty. Some of these have already 
been detected on Italian users, but as hundreds of other 
types are not yet listed in the “Tables” updated by the 
Ministry. Old and new generations of drugs are passing 
on the baton at a faster rate than bureaucratic proce-
dures, and Italy is struggling.
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Table 1 
Continued
Aminoindanes Benzodiazepines Piperidines and pyrrolidines Piperazines
MDAI Flubromazolam Ethylphenidate Benzylpiperazine
Amphetamines Plants and extracts Arylalkylamines Others
4-FMA Ibogaine MPA G-130
5-EAPB Mitragynine 2-MABB PRE-084
Fenbutrazate Mitragyna Speciosa 6-IT 2-MeO-difenidine
Phentermine Tabernanthe Iboga 5-APB NBOMe 4,4-dimethylaminorex
Mazindol Argyreia nervosa seeds 6-APB Afloqualone
Ipomoea violacea seeds 5-APB MMQ
Rivea corymbosa seeds 6-APDB W-18
5-APDB Phendimetrazine
5-IT Nandrolone
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